RT Generic
T1 A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial
A1 Rodríguez-Rubio, Miguel
A1 Figueira, Juan Carlos
A1 Acuña-Castroviejo, Darío
A1 Borobia, Alberto M.
A1 Escames, Germaine
A1 de la Oliva, Pedro
K1 COVID-19
K1 Randomized controlled trial
K1 Protocol
K1 Melatonin
K1 Treatment
K1 Intensive care
K1 ARDS
K1 Inflammation
K1 Infecciones por coronavirus
K1 Ensayo clínico controlado aleatorio
K1 Protocolo de ensayo clínico
K1 Melatonina
K1 Terapéutica
K1 Unidades de cuidados intensivos
K1 Síndrome de dificultad respiratoria del adulto
K1 Inflamación
PB BioMed Central
YR 2020
FD 2020-08-05
LK http://hdl.handle.net/10668/3393
UL http://hdl.handle.net/10668/3393
LA en
NO Rodríguez-Rubio M, Figueira JC, Acuña-Castroviejo D, Borobia AM, Escames G, de la Oliva P. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Aug 5;21(1):699.
DS RISalud
RD Apr 8, 2025